Progress in multidisciplinary treatment for esophageal cancer in Japan as reflected in JCOG studies Nobutoshi

Esophagus

Volumn 8, Issue 3, 2011, Pages 151-157

  Ando, Ando N ^a  

^a TOKYO DENTAL COLLEGE   (Japan)

Author keywords

Esophageal squamous cell carcinoma; JCOG; Multidisciplinary treatment; Surgical adjuvant Therapy

Indexed keywords

CISPLATIN; FLUOROURACIL; VINDESINE;

CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; CHEMORADIOTHERAPY; CONFERENCE PAPER; ESOPHAGUS CANCER; HUMAN; JAPAN; PERIOPERATIVE PERIOD; POSTOPERATIVE CARE; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROSPECTIVE STUDY;

EID: 81255157602     PISSN: 16129059     EISSN: 16129067     Source Type: Journal    
DOI: 10.1007/s10388-011-0282-8     Document Type: Conference Paper

References (25)

1. Shimoyama M, Fukuda H, Saijo N, et al. Japan Clinical Oncology Group (JCOG). Jpn J Clin Oncol. 1998;28:158-62. (Pubitemid 128525562)
2. Fukuda H. Development of cancer cooperative groups in Japan. Jpn J Clinic Oncol. 2010;40:881-9.
3. Akakura I, Nakamura Y, Kakegawa T, et al. Surgery of carcinoma of the esophagus with preoperative radiation. Chest. 1970;57:47-57.
4. Cooperative Clinical Study Group for Esophageal Carcinoma. Multidisciplinary treatment for esophageal carcinoma. Jpn J Clin Oncol. 1983;13:417-24.
5. Kasai M. Surgical treatment for carcinoma of the esophagus. J Jpn Surg Soc. 1980;81:845-53.
6. Iizuka T, Ide H, Kakegawa T, et al. Preoperative radioactive therapy for esophageal carcinoma. Randomized evaluation trial in eight institutions. Chest. 1988;93:1054-8.
7. Japanese Esophageal Oncology Group. A comparison of chemotherapy and radiotherapy as adjuvant treatment to surgery for esophageal carcinoma. Chest. 1993;104:203-7.
8. Ando N, Ozawa S, Kitagawa Y, Shinozawa Y, Kitajima M. Improvement in the results of surgical treatment of advanced squamous esophageal carcinoma during 15 consecutive years. Ann Surg. 2000;232:225-32. (Pubitemid 30616724)
9. Ando N, Iizuka T, Kakegawa T, et al. A randomized trial of surgery with and without chemotherapy for localized squamous carcinoma of the thoracic esophagus: the Japan Clinical Oncology Group Study. J Thorac Cardiovasc Surg. 1997;114:205-9. (Pubitemid 27364210)
10. Iizuka T, Kakegawa T, Ide H, et al. Phase II evaluation of cisplatin and vindesine in advanced squamous cell carcinoma of the esophagus: Japan Esophageal Oncology Group Trial. Jpn J Clin Oncol. 1991;21:176-9.
11. Iizuka T, Kakegawa T, Ide H, et al. Phase II evaluation of cisplatin and 5-fluorouracil in advanced squamous cell carcinoma of the esophagus: Japan Esophageal Oncology Group Trial. Jpn J Clin Oncol. 1992;22:172-6.
12. Ando N, Iizuka T, Ide H, et al. Surgery plus chemotherapy compared with surgery alone for localized squamous cell carcinoma of the thoracic esophagus: a Japan Clinical Oncology Group Study - JCOG 9204. J Clin Oncol. 2003;24:4592-6. (Pubitemid 46594032)
13. Kleinberg L, Forastiere A. Chemoradiation in the management of esophageal cancer. J Clin Oncol. 2007;25:4110-7. (Pubitemid 47492955)
14. Ando N, Kato H, Shinoda M, et al. A randomized trial of postoperative adjuvant chemotherapy with cisplatin and 5-fluorouracil versus neoadjuvant chemotherapy for localized squamous cell carcinoma of the thoracic esophagus (JCOG 9907). Proc 2008 Gastrointestinal Cancer Symposium, Orlando, USA.
15. Igaki H, Kato H, Ando N, et al. A randomized trial of postoperative adjuvant chemotherapy with cisplatin and 5-fluorouracil versus neoadjuvant chemotherapy for clinical stage II/III squamous cell carcinoma of the thoracic esophagus (JCOG 9907). Proc Am Soc Clin Oncol. 2008;26:215s.
16. Kelsen DP, Ginsberg R, Pajak TF, et al. Chemotherapy followed by surgery compared with surgery alone for localized esophageal cancer. N Engl J Med. 1998;339:1979-84. (Pubitemid 29024130)
17. Medical Research Council Oesophageal Cancer Working Party. Surgical resection with or without preoperative chemotherapy in oesophageal cancer: a randomised controlled trial. Lancet. 2002;359:1727-33.
18. Gebski V, Burmeister B, Smithers BM, et al. Survival benefits from neoadjuvant chemoradiotherapy or chemotherapy in oesophageal carcinoma: a meta-analysis. Lancet Oncol. 2007;8: 226-34. (Pubitemid 46291702)
19. Al-Sarraf M, Martz K, Herskovic A, et al. Progress report of combined chemoradiotherapy versus radiotherapy alone in patients with esophageal cancer: an intergroup study. J Clin Oncol. 2007;15:277-84.
20. Ishida K, Iizuka T, Ando N, et al. Phase II Study of chemoradiotherapy for advanced squamous cell carcinoma of the thoracic esophagus: nine Japanese Institute Trial. Jpn J Clin Oncol. 1996;26:310-5. (Pubitemid 126470689)
21. Ishida K, Ando N, Yamamoto S, et al. Phase II Study of cisplatin and 5-fluorouracil with concurrent radiotherapy in advanced squamous cell carcinoma of the esophagus: a Japan Esophageal Oncology Group (JEOG)/Japan Clinical Oncology Group Trial (JCOG9516). Jpn J Clin Oncol. 2004;34:615-9. (Pubitemid 40662717)
22. Shinoda M, Ando N, Kato H, et al. A multicenter randomized phase II (rPII)/III study comparing concurrent chemoradiotherapy (CRT) with low-dose cisplatin plus continuous infusion of 5-fluorouracil (LDPF) and standard-dose PF (SDPF) for locally advanced unresectable squamous cell carcinoma of the thoracic esophagus (JCOG0303). Proc Am Soc Clin Oncol. 2010;28:314s.
23. Kato H, Sato A, Fukuda H, et al. A phase II trial of chemoradiotherapy in patients with stage I esophageal squamous cell carcinoma: Japan Clinical Oncology Group study (JCOG 9708). Jpn J Clin Oncol. 2009;39:638-43.
24. Igaki H, Kato H, Tachimori Y, et al. Clinicopathologic characteristics and survival of patients with clinical Stage I squamous cell carcinoma of the thoracic esophagus treated with three-field lymph node dissection. Eur J Cardiothorac Surg. 2000;20: 1089-94. (Pubitemid 33051075)
25. Minashi K, Muro K, Kato K, et al. A phase II study of chemoradiotherapy in patients with stage II, III esophageal squamous cell carcinoma (ESSC): JCOG trial (JCOG9906). Proc 2008 Gastrointestinal Cancers Symposium.